LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
BT-20 JW-7-24-1
0.37
uM
LJP6
0.8549 0.0404 0.8216 0.0464
BT-20 JW-7-24-1
1.11
uM
LJP6
0.8043 0.0836 0.7550 0.1046
BT-20 JW-7-24-1
3.33
uM
LJP6
0.7000 0.1075 0.6104 0.1427
BT-20 JW-7-24-1
10
uM
LJP6
0.3034 0.0568 -0.0316 0.0957
BT-20 Dasatinib
0.04
uM
LJP5
0.8598 0.0354 0.8309 0.0419
BT-20 Dasatinib
0.04
uM
LJP6
0.5634 0.0919 0.4134 0.1224
BT-20 Dasatinib
0.12
uM
LJP5
0.6087 0.0091 0.4958 0.0232
BT-20 Dasatinib
0.12
uM
LJP6
0.4496 0.0825 0.2317 0.1180
BT-20 Dasatinib
0.37
uM
LJP5
0.3718 0.0170 0.1228 0.0268
BT-20 Dasatinib
0.37
uM
LJP6
0.3553 0.0482 0.0701 0.0635
BT-20 Dasatinib
1.11
uM
LJP5
0.3367 0.0269 0.0584 0.0489
BT-20 Dasatinib
1.11
uM
LJP6
0.2990 0.0209 -0.0334 0.0218
BT-20 Dasatinib
3.33
uM
LJP5
0.2912 0.0267 -0.0278 0.0482
BT-20 Dasatinib
3.33
uM
LJP6
0.2453 0.0156 -0.1421 0.0414
BT-20 Dasatinib
10
uM
LJP5
0.2618 0.0165 -0.0862 0.0416
BT-20 Dasatinib
10
uM
LJP6
0.2008 0.0080 -0.2400 0.0360
BT-20 Tozasertib
0.04
uM
LJP5
0.5355 0.0342 0.3849 0.0668
BT-20 Tozasertib
0.12
uM
LJP5
0.3392 0.0186 0.0628 0.0600
BT-20 Tozasertib
0.37
uM
LJP5
0.2944 0.0141 -0.0205 0.0543
BT-20 Tozasertib
1.11
uM
LJP5
0.2891 0.0201 -0.0318 0.0663
BT-20 Tozasertib
3.33
uM
LJP5
0.2871 0.0179 -0.0355 0.0617
BT-20 Tozasertib
10
uM
LJP5
0.2962 0.0205 -0.0179 0.0659
BT-20 Imatinib
0.04
uM
LJP6
1.0056 0.0147 1.0048 0.0188
BT-20 Imatinib
0.12
uM
LJP6
1.0162 0.0352 1.0157 0.0434
BT-20 Imatinib
0.37
uM
LJP6
0.9933 0.0135 0.9905 0.0172